Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-09-24

AUTHORS

Heiko Becker, Stefan Suciu, Björn Hans Rüter, Uwe Platzbecker, Aristoteles Giagounidis, Dominik Selleslag, Boris Labar, Ulrich Germing, Helmut R. Salih, Petra Muus, Karl-Heinz Pflüger, Anne Hagemeijer, Hans-Eckart Schaefer, Valeria Fiaccadori, Frédéric Baron, Arnold Ganser, Carlo Aul, Theo de Witte, Pierre W. Wijermans, Michael Lübbert

ABSTRACT

In the European Organisation for Research and Treatment of Cancer (EORTC)/GMDSSG phase III trial 06011, we compared decitabine (15 mg/m2 every 8 h for 3 days) with best supportive care (BSC) in patients ≥60 years with myelodysplastic syndromes (MDS) by French-American-British (FAB) criteria. Here, we reinvestigate trial 06011 for the activity and efficacy specifically in patients with refractory anemia with excess blasts in transformation (RAEBt). Response rates in the decitabine arm (N = 40) were as follows: complete or partial remission, 15 %; hematologic improvement, 15 %; resistant disease, 30 %. RAEBt patients in the decitabine arm had longer progression-free survival (PFS; hazard ratio (HR) 0.30, 95 % confidence interval (CI) 0.18–0.51; median, 6.2 vs 2.8 months) and overall survival (OS; HR 0.68, 95 % CI 0.42–1.11; median, 8.0 vs 6.0 months) than in the BSC arm (N = 35). Censoring at allogeneic hematopoietic stem cell transplantation, the OS difference between the treatment groups increased, particularly among patients aged 60–74 years (HR 0.48, 95 % CI 0.26–0.89). After regrouping the study cohort according to World Health Organization (WHO) criteria, patients with acute myeloid leukemia (AML) (i.e., ≥20 % blasts) in the decitabine arm (N = 27) also had longer PFS than in the BSC arm (N = 23) (HR 0.46, 95 % CI 0.26–0.83; median, 6.2 vs 2.8 months). In conclusion, 3-day decitabine displays clinical activity and efficacy in MDS and/or AML with 5–30 % blood or 20–30 % marrow blasts. More... »

PAGES

2003-2013

Journal

TITLE

Annals of Hematology

ISSUE

12

VOLUME

94

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-015-2489-6

DOI

http://dx.doi.org/10.1007/s00277-015-2489-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046103336

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26400023


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anemia, Refractory, with Excess of Blasts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Azacitidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blast Crisis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Decitabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine I, Medical Center-University of Freiburg, Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7708.8", 
          "name": [
            "Department of Medicine I, Medical Center-University of Freiburg, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Becker", 
        "givenName": "Heiko", 
        "id": "sg:person.0631556757.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631556757.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "EORTC Headquarters, Brussels, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.418936.1", 
          "name": [
            "EORTC Headquarters, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suciu", 
        "givenName": "Stefan", 
        "id": "sg:person.01014211567.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014211567.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine I, Medical Center-University of Freiburg, Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7708.8", 
          "name": [
            "Department of Medicine I, Medical Center-University of Freiburg, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "R\u00fcter", 
        "givenName": "Bj\u00f6rn Hans", 
        "id": "sg:person.0750355777.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750355777.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine I, University Carl Gustav Carus, Dresden, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine I, University Carl Gustav Carus, Dresden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Platzbecker", 
        "givenName": "Uwe", 
        "id": "sg:person.0670313557.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670313557.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Palliative Care, Marienhospital D\u00fcsseldorf, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Oncology and Palliative Care, Marienhospital D\u00fcsseldorf, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giagounidis", 
        "givenName": "Aristoteles", 
        "id": "sg:person.01164215515.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164215515.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, AZ St-Jan, Brugge, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.420036.3", 
          "name": [
            "Department of Hematology, AZ St-Jan, Brugge, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Selleslag", 
        "givenName": "Dominik", 
        "id": "sg:person.07711475767.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07711475767.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Center Rebro, Zagreb, Croatia", 
          "id": "http://www.grid.ac/institutes/grid.412688.1", 
          "name": [
            "University Hospital Center Rebro, Zagreb, Croatia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Labar", 
        "givenName": "Boris", 
        "id": "sg:person.01104727454.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104727454.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Germing", 
        "givenName": "Ulrich", 
        "id": "sg:person.01362464041.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Immunology, Eberhard Karls University, T\u00fcbingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.10392.39", 
          "name": [
            "Department of Hematology, Oncology and Immunology, Eberhard Karls University, T\u00fcbingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salih", 
        "givenName": "Helmut R.", 
        "id": "sg:person.0647531537.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647531537.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radboud University Medical Center, Nijmegen, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Radboud University Medical Center, Nijmegen, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Muus", 
        "givenName": "Petra", 
        "id": "sg:person.01054761151.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054761151.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine II, DIAKO Bremen, Bremen, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Medicine II, DIAKO Bremen, Bremen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pfl\u00fcger", 
        "givenName": "Karl-Heinz", 
        "id": "sg:person.0677051610.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677051610.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Human Genetics, University of Leuven, Leuven, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.5596.f", 
          "name": [
            "Center for Human Genetics, University of Leuven, Leuven, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hagemeijer", 
        "givenName": "Anne", 
        "id": "sg:person.01102221607.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102221607.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Pathology, University of Freiburg, Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.5963.9", 
          "name": [
            "Institute of Pathology, University of Freiburg, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schaefer", 
        "givenName": "Hans-Eckart", 
        "id": "sg:person.01116304300.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116304300.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "EORTC Headquarters, Brussels, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.418936.1", 
          "name": [
            "EORTC Headquarters, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fiaccadori", 
        "givenName": "Valeria", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire Sart-Tilman, Li\u00e8ge, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.411374.4", 
          "name": [
            "Centre Hospitalier Universitaire Sart-Tilman, Li\u00e8ge, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baron", 
        "givenName": "Fr\u00e9d\u00e9ric", 
        "id": "sg:person.0701462103.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701462103.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany", 
          "id": "http://www.grid.ac/institutes/grid.10423.34", 
          "name": [
            "Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ganser", 
        "givenName": "Arnold", 
        "id": "sg:person.01225227464.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225227464.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, St. Johannes Hospital, Duisburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.459950.4", 
          "name": [
            "Department of Hematology and Oncology, St. Johannes Hospital, Duisburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aul", 
        "givenName": "Carlo", 
        "id": "sg:person.01300444115.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300444115.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radboud University Medical Center, Nijmegen, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Radboud University Medical Center, Nijmegen, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Witte", 
        "givenName": "Theo", 
        "id": "sg:person.015730551677.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015730551677.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Haga Ziekenhuis, The Hague, Netherlands", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Haga Ziekenhuis, The Hague, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wijermans", 
        "givenName": "Pierre W.", 
        "id": "sg:person.010061377417.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010061377417.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine I, Medical Center-University of Freiburg, Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7708.8", 
          "name": [
            "Department of Medicine I, Medical Center-University of Freiburg, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "L\u00fcbbert", 
        "givenName": "Michael", 
        "id": "sg:person.01153663723.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153663723.53"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00277-012-1595-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042713302", 
          "https://doi.org/10.1007/s00277-012-1595-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-013-1702-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009533874", 
          "https://doi.org/10.1007/s00277-013-1702-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2162-3619-3-10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020837377", 
          "https://doi.org/10.1186/2162-3619-3-10"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2400550", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034237061", 
          "https://doi.org/10.1038/sj.leu.2400550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2013.173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047612708", 
          "https://doi.org/10.1038/leu.2013.173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-012-1635-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012930838", 
          "https://doi.org/10.1007/s00277-012-1635-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2011.342", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008195860", 
          "https://doi.org/10.1038/leu.2011.342"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-09-24", 
    "datePublishedReg": "2015-09-24", 
    "description": "In the European Organisation for Research and Treatment of Cancer (EORTC)/GMDSSG phase III trial 06011, we compared decitabine (15\u00a0mg/m2 every 8\u00a0h for 3\u00a0days) with best supportive care (BSC) in patients \u226560\u00a0years with myelodysplastic syndromes (MDS) by French-American-British (FAB) criteria. Here, we reinvestigate trial 06011 for the activity and efficacy specifically in patients with refractory anemia with excess blasts in transformation (RAEBt). Response rates in the decitabine arm (N\u2009=\u200940) were as follows: complete or partial remission, 15\u00a0%; hematologic improvement, 15\u00a0%; resistant disease, 30\u00a0%. RAEBt patients in the decitabine arm had longer progression-free survival (PFS; hazard ratio (HR) 0.30, 95\u00a0% confidence interval (CI) 0.18\u20130.51; median, 6.2 vs 2.8\u00a0months) and overall survival (OS; HR 0.68, 95\u00a0% CI 0.42\u20131.11; median, 8.0 vs 6.0\u00a0months) than in the BSC arm (N\u2009=\u200935). Censoring at allogeneic hematopoietic stem cell transplantation, the OS difference between the treatment groups increased, particularly among patients aged 60\u201374\u00a0years (HR 0.48, 95\u00a0% CI 0.26\u20130.89). After regrouping the study cohort according to World Health Organization (WHO) criteria, patients with acute myeloid leukemia (AML) (i.e., \u226520\u00a0% blasts) in the decitabine arm (N\u2009=\u200927) also had longer PFS than in the BSC arm (N\u2009=\u200923) (HR 0.46, 95\u00a0% CI 0.26\u20130.83; median, 6.2 vs 2.8\u00a0months). In conclusion, 3-day decitabine displays clinical activity and efficacy in MDS and/or AML with 5\u201330\u00a0% blood or 20\u201330\u00a0% marrow blasts.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-015-2489-6", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "94"
      }
    ], 
    "keywords": [
      "best supportive care", 
      "acute myeloid leukemia", 
      "German MDS Study Group", 
      "myelodysplastic syndrome", 
      "BSC arm", 
      "supportive care", 
      "excess blasts", 
      "refractory anemia", 
      "allogeneic hematopoietic stem cell transplantation", 
      "EORTC Leukemia Cooperative Group", 
      "longer progression-free survival", 
      "hematopoietic stem cell transplantation", 
      "World Health Organization criteria", 
      "Leukemia Cooperative Group", 
      "progression-free survival", 
      "stem cell transplantation", 
      "RAEBt patients", 
      "partial remission", 
      "hematologic improvement", 
      "longer PFS", 
      "overall survival", 
      "marrow blasts", 
      "older patients", 
      "resistant disease", 
      "study cohort", 
      "treatment of cancer", 
      "cell transplantation", 
      "Organization criteria", 
      "subgroup analysis", 
      "myeloid leukemia", 
      "clinical activity", 
      "OS difference", 
      "study group", 
      "treatment groups", 
      "patients", 
      "British (FAB) criteria", 
      "response rate", 
      "European Organization", 
      "cooperative groups", 
      "anemia", 
      "decitabine", 
      "care", 
      "efficacy", 
      "survival", 
      "arm", 
      "group", 
      "blasts", 
      "remission", 
      "transplantation", 
      "syndrome", 
      "PFS", 
      "cohort", 
      "leukemia", 
      "years", 
      "cancer", 
      "disease", 
      "blood", 
      "treatment", 
      "criteria", 
      "activity", 
      "conclusion", 
      "differences", 
      "rate", 
      "improvement", 
      "analysis", 
      "research", 
      "organization", 
      "transformation"
    ], 
    "name": "Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG)", 
    "pagination": "2003-2013", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046103336"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-015-2489-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26400023"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-015-2489-6", 
      "https://app.dimensions.ai/details/publication/pub.1046103336"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_679.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-015-2489-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2489-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2489-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2489-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2489-6'


 

This table displays all metadata directly associated to this object as RDF triples.

383 TRIPLES      21 PREDICATES      113 URIs      98 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-015-2489-6 schema:about N1f32b4155ea44084a0d35501e31a8abb
2 N336687f977324c9a8f24f62938149c17
3 N3b7f5e208b764198a0db6778a1124415
4 N45f2a39012e843e4817a43dd6e821a8e
5 N9ea892d6ae29454caa4b658789ef937f
6 Na5ad8327309247569222e8d779dfebb6
7 Ncd9dad82b34e4dbc9553026038a27a74
8 Nd2f549a409d546e39c94f13fc535d5d1
9 Neeb77c87ae2a4f68bcb93792afd797d2
10 Nf264d38d33a34bf5a80fcce7ceb2c571
11 Nf3fb99fb6466491aa479335596fabf13
12 Nf718c57ce7c140849847c26f2f829ef9
13 Nfb4fbc4f3ce54fdfab593348ca8f687a
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author Nc04db01e4e3247729d7551ef28da47a1
17 schema:citation sg:pub.10.1007/s00277-012-1595-y
18 sg:pub.10.1007/s00277-012-1635-7
19 sg:pub.10.1007/s00277-013-1702-8
20 sg:pub.10.1038/leu.2011.342
21 sg:pub.10.1038/leu.2013.173
22 sg:pub.10.1038/sj.leu.2400550
23 sg:pub.10.1186/2162-3619-3-10
24 schema:datePublished 2015-09-24
25 schema:datePublishedReg 2015-09-24
26 schema:description In the European Organisation for Research and Treatment of Cancer (EORTC)/GMDSSG phase III trial 06011, we compared decitabine (15 mg/m2 every 8 h for 3 days) with best supportive care (BSC) in patients ≥60 years with myelodysplastic syndromes (MDS) by French-American-British (FAB) criteria. Here, we reinvestigate trial 06011 for the activity and efficacy specifically in patients with refractory anemia with excess blasts in transformation (RAEBt). Response rates in the decitabine arm (N = 40) were as follows: complete or partial remission, 15 %; hematologic improvement, 15 %; resistant disease, 30 %. RAEBt patients in the decitabine arm had longer progression-free survival (PFS; hazard ratio (HR) 0.30, 95 % confidence interval (CI) 0.18–0.51; median, 6.2 vs 2.8 months) and overall survival (OS; HR 0.68, 95 % CI 0.42–1.11; median, 8.0 vs 6.0 months) than in the BSC arm (N = 35). Censoring at allogeneic hematopoietic stem cell transplantation, the OS difference between the treatment groups increased, particularly among patients aged 60–74 years (HR 0.48, 95 % CI 0.26–0.89). After regrouping the study cohort according to World Health Organization (WHO) criteria, patients with acute myeloid leukemia (AML) (i.e., ≥20 % blasts) in the decitabine arm (N = 27) also had longer PFS than in the BSC arm (N = 23) (HR 0.46, 95 % CI 0.26–0.83; median, 6.2 vs 2.8 months). In conclusion, 3-day decitabine displays clinical activity and efficacy in MDS and/or AML with 5–30 % blood or 20–30 % marrow blasts.
27 schema:genre article
28 schema:isAccessibleForFree true
29 schema:isPartOf Nd69956bc252e4ea182f77eb1c5460556
30 Nfd713cbc87e040978b5d228bf25af9cb
31 sg:journal.1358129
32 schema:keywords BSC arm
33 British (FAB) criteria
34 EORTC Leukemia Cooperative Group
35 European Organization
36 German MDS Study Group
37 Leukemia Cooperative Group
38 OS difference
39 Organization criteria
40 PFS
41 RAEBt patients
42 World Health Organization criteria
43 activity
44 acute myeloid leukemia
45 allogeneic hematopoietic stem cell transplantation
46 analysis
47 anemia
48 arm
49 best supportive care
50 blasts
51 blood
52 cancer
53 care
54 cell transplantation
55 clinical activity
56 cohort
57 conclusion
58 cooperative groups
59 criteria
60 decitabine
61 differences
62 disease
63 efficacy
64 excess blasts
65 group
66 hematologic improvement
67 hematopoietic stem cell transplantation
68 improvement
69 leukemia
70 longer PFS
71 longer progression-free survival
72 marrow blasts
73 myelodysplastic syndrome
74 myeloid leukemia
75 older patients
76 organization
77 overall survival
78 partial remission
79 patients
80 progression-free survival
81 rate
82 refractory anemia
83 remission
84 research
85 resistant disease
86 response rate
87 stem cell transplantation
88 study cohort
89 study group
90 subgroup analysis
91 supportive care
92 survival
93 syndrome
94 transformation
95 transplantation
96 treatment
97 treatment groups
98 treatment of cancer
99 years
100 schema:name Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG)
101 schema:pagination 2003-2013
102 schema:productId N2853fa9e87c34eb6923be6d1041594ad
103 N577f0e89b27641feb61f4deec4875977
104 Nd000e09b26ec4b02a04c7de9d57a046b
105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046103336
106 https://doi.org/10.1007/s00277-015-2489-6
107 schema:sdDatePublished 2022-08-04T17:04
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher Nbc48728f1a0d41d3810df0be47f0b1ea
110 schema:url https://doi.org/10.1007/s00277-015-2489-6
111 sgo:license sg:explorer/license/
112 sgo:sdDataset articles
113 rdf:type schema:ScholarlyArticle
114 N00ffa4ae7ebc489cbae21855cafd342b rdf:first sg:person.0670313557.25
115 rdf:rest N6d76b48950ca40f1bc5f59b675aed98c
116 N0878ba9b2d5e494a8b591daf9bb3cf04 schema:affiliation grid-institutes:grid.418936.1
117 schema:familyName Fiaccadori
118 schema:givenName Valeria
119 rdf:type schema:Person
120 N1f32b4155ea44084a0d35501e31a8abb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Aged, 80 and over
122 rdf:type schema:DefinedTerm
123 N250dda21195249beae7da69409880175 rdf:first sg:person.015730551677.08
124 rdf:rest N3e981220f95b42f089e3403fe0951008
125 N2853fa9e87c34eb6923be6d1041594ad schema:name pubmed_id
126 schema:value 26400023
127 rdf:type schema:PropertyValue
128 N336687f977324c9a8f24f62938149c17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Anemia, Refractory, with Excess of Blasts
130 rdf:type schema:DefinedTerm
131 N3b7f5e208b764198a0db6778a1124415 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Male
133 rdf:type schema:DefinedTerm
134 N3e981220f95b42f089e3403fe0951008 rdf:first sg:person.010061377417.22
135 rdf:rest Nead42cc828194092bda6523151b6f1e5
136 N435e0c8bda8b476ab6ec04f9da8731f4 rdf:first N0878ba9b2d5e494a8b591daf9bb3cf04
137 rdf:rest Nf13122cc66a84463aa2cf5f369591ab5
138 N45f2a39012e843e4817a43dd6e821a8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Antimetabolites, Antineoplastic
140 rdf:type schema:DefinedTerm
141 N46904fa0cb634fca873822c1898bb5a7 rdf:first sg:person.01014211567.13
142 rdf:rest Na87dd764f3a54aafa13b2cc3df8d8030
143 N46c0a51a593d428584bef4360b240e93 rdf:first sg:person.01116304300.49
144 rdf:rest N435e0c8bda8b476ab6ec04f9da8731f4
145 N577f0e89b27641feb61f4deec4875977 schema:name dimensions_id
146 schema:value pub.1046103336
147 rdf:type schema:PropertyValue
148 N58f01d3949d1495b89eede94e32b1a6d rdf:first sg:person.07711475767.54
149 rdf:rest N9dc0633b685a48bc9351ae90aabc2b5f
150 N68cb72cd72524aebaeae7d4efedb69fb rdf:first sg:person.01102221607.57
151 rdf:rest N46c0a51a593d428584bef4360b240e93
152 N6d76b48950ca40f1bc5f59b675aed98c rdf:first sg:person.01164215515.10
153 rdf:rest N58f01d3949d1495b89eede94e32b1a6d
154 N7b20926ce7084c6d997f09619bc82f73 rdf:first sg:person.01225227464.09
155 rdf:rest N8ed8f341395540e8842e560d0ea2f5e6
156 N8ed8f341395540e8842e560d0ea2f5e6 rdf:first sg:person.01300444115.40
157 rdf:rest N250dda21195249beae7da69409880175
158 N9dc0633b685a48bc9351ae90aabc2b5f rdf:first sg:person.01104727454.92
159 rdf:rest Nf7a493b34f8242fcb8c9e1f606672ca7
160 N9ea892d6ae29454caa4b658789ef937f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Survival Rate
162 rdf:type schema:DefinedTerm
163 Na0a605a1d99c4eae9cacabef092e6a58 rdf:first sg:person.01054761151.73
164 rdf:rest Na7277547d9b54214a2d35f1030a6ac8c
165 Na5ad8327309247569222e8d779dfebb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Blast Crisis
167 rdf:type schema:DefinedTerm
168 Na7277547d9b54214a2d35f1030a6ac8c rdf:first sg:person.0677051610.01
169 rdf:rest N68cb72cd72524aebaeae7d4efedb69fb
170 Na87dd764f3a54aafa13b2cc3df8d8030 rdf:first sg:person.0750355777.66
171 rdf:rest N00ffa4ae7ebc489cbae21855cafd342b
172 Nb04329a61f694850a46dfdfca4ea21a2 rdf:first sg:person.0647531537.09
173 rdf:rest Na0a605a1d99c4eae9cacabef092e6a58
174 Nbc48728f1a0d41d3810df0be47f0b1ea schema:name Springer Nature - SN SciGraph project
175 rdf:type schema:Organization
176 Nc04db01e4e3247729d7551ef28da47a1 rdf:first sg:person.0631556757.06
177 rdf:rest N46904fa0cb634fca873822c1898bb5a7
178 Ncd9dad82b34e4dbc9553026038a27a74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Female
180 rdf:type schema:DefinedTerm
181 Nd000e09b26ec4b02a04c7de9d57a046b schema:name doi
182 schema:value 10.1007/s00277-015-2489-6
183 rdf:type schema:PropertyValue
184 Nd2f549a409d546e39c94f13fc535d5d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Aged
186 rdf:type schema:DefinedTerm
187 Nd69956bc252e4ea182f77eb1c5460556 schema:volumeNumber 94
188 rdf:type schema:PublicationVolume
189 Nead42cc828194092bda6523151b6f1e5 rdf:first sg:person.01153663723.53
190 rdf:rest rdf:nil
191 Neeb77c87ae2a4f68bcb93792afd797d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Azacitidine
193 rdf:type schema:DefinedTerm
194 Nf13122cc66a84463aa2cf5f369591ab5 rdf:first sg:person.0701462103.33
195 rdf:rest N7b20926ce7084c6d997f09619bc82f73
196 Nf264d38d33a34bf5a80fcce7ceb2c571 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Decitabine
198 rdf:type schema:DefinedTerm
199 Nf3fb99fb6466491aa479335596fabf13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Middle Aged
201 rdf:type schema:DefinedTerm
202 Nf718c57ce7c140849847c26f2f829ef9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Humans
204 rdf:type schema:DefinedTerm
205 Nf7a493b34f8242fcb8c9e1f606672ca7 rdf:first sg:person.01362464041.20
206 rdf:rest Nb04329a61f694850a46dfdfca4ea21a2
207 Nfb4fbc4f3ce54fdfab593348ca8f687a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Disease-Free Survival
209 rdf:type schema:DefinedTerm
210 Nfd713cbc87e040978b5d228bf25af9cb schema:issueNumber 12
211 rdf:type schema:PublicationIssue
212 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
213 schema:name Medical and Health Sciences
214 rdf:type schema:DefinedTerm
215 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
216 schema:name Oncology and Carcinogenesis
217 rdf:type schema:DefinedTerm
218 sg:journal.1358129 schema:issn 0939-5555
219 1432-0584
220 schema:name Annals of Hematology
221 schema:publisher Springer Nature
222 rdf:type schema:Periodical
223 sg:person.010061377417.22 schema:affiliation grid-institutes:None
224 schema:familyName Wijermans
225 schema:givenName Pierre W.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010061377417.22
227 rdf:type schema:Person
228 sg:person.01014211567.13 schema:affiliation grid-institutes:grid.418936.1
229 schema:familyName Suciu
230 schema:givenName Stefan
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014211567.13
232 rdf:type schema:Person
233 sg:person.01054761151.73 schema:affiliation grid-institutes:grid.10417.33
234 schema:familyName Muus
235 schema:givenName Petra
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054761151.73
237 rdf:type schema:Person
238 sg:person.01102221607.57 schema:affiliation grid-institutes:grid.5596.f
239 schema:familyName Hagemeijer
240 schema:givenName Anne
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102221607.57
242 rdf:type schema:Person
243 sg:person.01104727454.92 schema:affiliation grid-institutes:grid.412688.1
244 schema:familyName Labar
245 schema:givenName Boris
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104727454.92
247 rdf:type schema:Person
248 sg:person.01116304300.49 schema:affiliation grid-institutes:grid.5963.9
249 schema:familyName Schaefer
250 schema:givenName Hans-Eckart
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116304300.49
252 rdf:type schema:Person
253 sg:person.01153663723.53 schema:affiliation grid-institutes:grid.7708.8
254 schema:familyName Lübbert
255 schema:givenName Michael
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153663723.53
257 rdf:type schema:Person
258 sg:person.01164215515.10 schema:affiliation grid-institutes:None
259 schema:familyName Giagounidis
260 schema:givenName Aristoteles
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164215515.10
262 rdf:type schema:Person
263 sg:person.01225227464.09 schema:affiliation grid-institutes:grid.10423.34
264 schema:familyName Ganser
265 schema:givenName Arnold
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225227464.09
267 rdf:type schema:Person
268 sg:person.01300444115.40 schema:affiliation grid-institutes:grid.459950.4
269 schema:familyName Aul
270 schema:givenName Carlo
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300444115.40
272 rdf:type schema:Person
273 sg:person.01362464041.20 schema:affiliation grid-institutes:grid.14778.3d
274 schema:familyName Germing
275 schema:givenName Ulrich
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20
277 rdf:type schema:Person
278 sg:person.015730551677.08 schema:affiliation grid-institutes:grid.10417.33
279 schema:familyName de Witte
280 schema:givenName Theo
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015730551677.08
282 rdf:type schema:Person
283 sg:person.0631556757.06 schema:affiliation grid-institutes:grid.7708.8
284 schema:familyName Becker
285 schema:givenName Heiko
286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631556757.06
287 rdf:type schema:Person
288 sg:person.0647531537.09 schema:affiliation grid-institutes:grid.10392.39
289 schema:familyName Salih
290 schema:givenName Helmut R.
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647531537.09
292 rdf:type schema:Person
293 sg:person.0670313557.25 schema:affiliation grid-institutes:None
294 schema:familyName Platzbecker
295 schema:givenName Uwe
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670313557.25
297 rdf:type schema:Person
298 sg:person.0677051610.01 schema:affiliation grid-institutes:None
299 schema:familyName Pflüger
300 schema:givenName Karl-Heinz
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677051610.01
302 rdf:type schema:Person
303 sg:person.0701462103.33 schema:affiliation grid-institutes:grid.411374.4
304 schema:familyName Baron
305 schema:givenName Frédéric
306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701462103.33
307 rdf:type schema:Person
308 sg:person.0750355777.66 schema:affiliation grid-institutes:grid.7708.8
309 schema:familyName Rüter
310 schema:givenName Björn Hans
311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750355777.66
312 rdf:type schema:Person
313 sg:person.07711475767.54 schema:affiliation grid-institutes:grid.420036.3
314 schema:familyName Selleslag
315 schema:givenName Dominik
316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07711475767.54
317 rdf:type schema:Person
318 sg:pub.10.1007/s00277-012-1595-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1042713302
319 https://doi.org/10.1007/s00277-012-1595-y
320 rdf:type schema:CreativeWork
321 sg:pub.10.1007/s00277-012-1635-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012930838
322 https://doi.org/10.1007/s00277-012-1635-7
323 rdf:type schema:CreativeWork
324 sg:pub.10.1007/s00277-013-1702-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009533874
325 https://doi.org/10.1007/s00277-013-1702-8
326 rdf:type schema:CreativeWork
327 sg:pub.10.1038/leu.2011.342 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008195860
328 https://doi.org/10.1038/leu.2011.342
329 rdf:type schema:CreativeWork
330 sg:pub.10.1038/leu.2013.173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047612708
331 https://doi.org/10.1038/leu.2013.173
332 rdf:type schema:CreativeWork
333 sg:pub.10.1038/sj.leu.2400550 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034237061
334 https://doi.org/10.1038/sj.leu.2400550
335 rdf:type schema:CreativeWork
336 sg:pub.10.1186/2162-3619-3-10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020837377
337 https://doi.org/10.1186/2162-3619-3-10
338 rdf:type schema:CreativeWork
339 grid-institutes:None schema:alternateName Department of Hematology, Oncology and Palliative Care, Marienhospital Düsseldorf, Düsseldorf, Germany
340 Department of Internal Medicine I, University Carl Gustav Carus, Dresden, Germany
341 Department of Internal Medicine, Haga Ziekenhuis, The Hague, Netherlands
342 Department of Medicine II, DIAKO Bremen, Bremen, Germany
343 schema:name Department of Hematology, Oncology and Palliative Care, Marienhospital Düsseldorf, Düsseldorf, Germany
344 Department of Internal Medicine I, University Carl Gustav Carus, Dresden, Germany
345 Department of Internal Medicine, Haga Ziekenhuis, The Hague, Netherlands
346 Department of Medicine II, DIAKO Bremen, Bremen, Germany
347 rdf:type schema:Organization
348 grid-institutes:grid.10392.39 schema:alternateName Department of Hematology, Oncology and Immunology, Eberhard Karls University, Tübingen, Germany
349 schema:name Department of Hematology, Oncology and Immunology, Eberhard Karls University, Tübingen, Germany
350 rdf:type schema:Organization
351 grid-institutes:grid.10417.33 schema:alternateName Radboud University Medical Center, Nijmegen, Netherlands
352 schema:name Radboud University Medical Center, Nijmegen, Netherlands
353 rdf:type schema:Organization
354 grid-institutes:grid.10423.34 schema:alternateName Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
355 schema:name Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
356 rdf:type schema:Organization
357 grid-institutes:grid.14778.3d schema:alternateName Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
358 schema:name Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
359 rdf:type schema:Organization
360 grid-institutes:grid.411374.4 schema:alternateName Centre Hospitalier Universitaire Sart-Tilman, Liège, Belgium
361 schema:name Centre Hospitalier Universitaire Sart-Tilman, Liège, Belgium
362 rdf:type schema:Organization
363 grid-institutes:grid.412688.1 schema:alternateName University Hospital Center Rebro, Zagreb, Croatia
364 schema:name University Hospital Center Rebro, Zagreb, Croatia
365 rdf:type schema:Organization
366 grid-institutes:grid.418936.1 schema:alternateName EORTC Headquarters, Brussels, Belgium
367 schema:name EORTC Headquarters, Brussels, Belgium
368 rdf:type schema:Organization
369 grid-institutes:grid.420036.3 schema:alternateName Department of Hematology, AZ St-Jan, Brugge, Belgium
370 schema:name Department of Hematology, AZ St-Jan, Brugge, Belgium
371 rdf:type schema:Organization
372 grid-institutes:grid.459950.4 schema:alternateName Department of Hematology and Oncology, St. Johannes Hospital, Duisburg, Germany
373 schema:name Department of Hematology and Oncology, St. Johannes Hospital, Duisburg, Germany
374 rdf:type schema:Organization
375 grid-institutes:grid.5596.f schema:alternateName Center for Human Genetics, University of Leuven, Leuven, Belgium
376 schema:name Center for Human Genetics, University of Leuven, Leuven, Belgium
377 rdf:type schema:Organization
378 grid-institutes:grid.5963.9 schema:alternateName Institute of Pathology, University of Freiburg, Freiburg, Germany
379 schema:name Institute of Pathology, University of Freiburg, Freiburg, Germany
380 rdf:type schema:Organization
381 grid-institutes:grid.7708.8 schema:alternateName Department of Medicine I, Medical Center-University of Freiburg, Freiburg, Germany
382 schema:name Department of Medicine I, Medical Center-University of Freiburg, Freiburg, Germany
383 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...